NIH-funded research Career grant

Understanding how the immune system controls cancer cell selection in the colon

Official title: Immune control of oncogene selection in preneoplastic colon

Funded at Yale University · NIH-10929458 · Data updated 2026-11-12

This study is looking at how the immune system can help stop certain mutated cells in the colon, which can lead to cancer, especially in older women, and it hopes to find new ways to boost our body's defenses against these harmful cells.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 14, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$185,314
NIH project number5K08CA277003-02
Project IDNIH-10929458 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women aged 65 and older who are at risk for developing colon cancer, particularly those with the BRAFV600E mutation.

Less likely to help

Patients who are younger than 65 or do not have the BRAFV600E mutation may not benefit from this research.

What this research studies

This research investigates how the immune system can prevent the selection of mutated stem cells in the colon that may lead to cancer. It focuses on a specific mutation, BRAFV600E, which is common in colon cancers affecting older women. By using genetically modified mice, the study aims to uncover the mechanisms by which regulatory T cells recognize and suppress these mutated cells. The findings could pave the way for new therapies aimed at preventing colon cancer by enhancing immune surveillance.

Why it matters

Potential benefit: If successful, this research could lead to new immune-based therapies that prevent the development of colon cancer in at-risk populations.

How similar studies have gone: Previous research has shown promising results in understanding immune mechanisms in cancer prevention, suggesting that this approach could be effective.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Mirza, Haris — Yale University
  • Study coordinator: Mirza, Haris

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.